Consumer perspectives on weight care

Headlines about innovative obesity solutions and GLP-1s continue to roll in, but most of the current discourse has been centered on the perspectives of pharma players, providers, payers, employers, and startups. To hear directly from consumers, we engaged direct-to-patient research platform Evidation to conduct the 2024 Rock Health Weight Care Experience Survey Series—surveying thousands of individuals about their use of weight care solutions like digital tools and prescription medications including GLP-1s. Our latest piece shares findings from the survey series, exploring utilization of different weight loss methods, barriers to accessing GLP-1s, and the types of wraparound support consumers want in their weight loss journeys.

We are excited to share the first installment of this year’s Rock Health Summit Virtual Series, which features expert perspectives on opportunities for aging innovation. Hear from Cameron Carter (Rosarium Health), Abby Levy (Primetime Partners), Rigo Saborio (The SCAN Foundation), and Adriana Krasniansky (Rock Health) as they discuss the tools needed to support senior communities.

Interested in more content like this? Join us at Rock Health Summit on 9/10.

Headlines

Digital-Health Venture Investment Rises, But Many Deals Have Yet To Pay Off
Recapping digital health investment in the first half of 2024 The Wall Street Journal

Medicare Proposes To Cover Some Digital Therapies In A Breakthrough For Health Tech Firms
New CMS codes reimburse software-based treatments, including for mental health STAT

OpenAI Startup Fund, Arianna Huffington Back New AI Health Coach Venture
Thrive AI Health will serve as a personal health coach focused on chronic conditions Fierce Healthcare

F.T.C. Slams Middlemen For High Drug Prices, Reversing Hands-Off Approach
Lawsuits could be filed against PBMs for abusive drug price negotiation The New York Times

Insurers Pocketed $50B From Medicare For Diseases No Doctor Treated
Fraudulent Medicare Advantage payments capitalized on diagnoses that pay more The Wall Street Journal

Recent Funding